LENSKART SOLUTIONS
Back to Cashflow Statement
|
LENSKART SOLUTIONS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-535 Cr | ₹-722 Cr | ₹2,777 Cr | ₹604 Cr | ₹-16 Cr |
What is the latest Cash Flow from Financing Activities ratio of LENSKART SOLUTIONS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-535 Cr |
| Mar2024 | ₹-722 Cr |
| Mar2023 | ₹2,777 Cr |
| Mar2022 | ₹604 Cr |
| Mar2021 | ₹-16 Cr |
How is Cash Flow from Financing Activities of LENSKART SOLUTIONS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-535 Cr | Negative | |
| Mar2024 | ₹-722 Cr | Negative | |
| Mar2023 | ₹2,777 Cr | 359.57 | |
| Mar2022 | ₹604 Cr | Positive | |
| Mar2021 | ₹-16 Cr | - | |
Compare Cash Flow from Financing Activities of peers of LENSKART SOLUTIONS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LENSKART SOLUTIONS | ₹92,342.4 Cr | 4.5% | 1.4% | NA | Stock Analytics | |
| POLY MEDICURE | ₹17,614.2 Cr | 5.3% | 31.5% | -24.1% | Stock Analytics | |
| LAXMI DENTAL | ₹1,235.8 Cr | 0% | -5.2% | -48% | Stock Analytics | |
| 3B BLACKBIO DX | ₹1,036.6 Cr | 3.9% | 8.2% | -15.9% | Stock Analytics | |
| PREVEST DENPRO | ₹453.8 Cr | -0.7% | -2.6% | -19.5% | Stock Analytics | |
| NURECA | ₹225.6 Cr | -0.7% | -0.5% | -17.2% | Stock Analytics | |
LENSKART SOLUTIONS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LENSKART SOLUTIONS | 4.5% |
1.4% |
|
| SENSEX | 0.7% |
4.4% |
-5.6% |
You may also like the below Video Courses